Second‐degree burn induced by high‐concentration topical capsaicin with mobility sequelae: A case report

por Trin, Kilian, Perino, Justine, Allouchery, Marion, Géniaux, Hélène, Miremont, Ghada, Salvo, Francesco
Publicado 2022

Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database

por Allouchery, Marion, Tomowiak, Cécile, Lombard, Thomas, Pérault-Pochat, Marie-Christine, Salvo, Francesco
Publicado 2021

Safety of Immune Checkpoint Inhibitor Resumption after Interruption for Immune-Related Adverse Events, a Narrative Review

por Allouchery, Marion, Beuvon, Clément, Pérault-Pochat, Marie-Christine, Roblot, Pascal, Puyade, Mathieu, Martin, Mickaël
Publicado 2022

Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer

por Allouchery, Marion, Lombard, Thomas, Martin, Mickael, Rouby, Franck, Sassier, Marion, Bertin, Celia, Atzenhoffer, Marina, Miremont-Salame, Ghada, Perault-Pochat, Marie-Christine, Puyade, Mathieu
Publicado 2020

Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database

por Martin, Mickaël, Nguyen, Hoan-My, Beuvon, Clément, Bene, Johana, Palassin, Pascale, Atzenhoffer, Marina, Rouby, Franck, Sassier, Marion, Pérault-Pochat, Marie-Christine, Roblot, Pascal, Allouchery, Marion, Puyade, Mathieu
Publicado 2022